[Story ID: 3498] Stand Up To Cancer (SU2C) and Virgin America, the California-based airline that is reinventing travel, today announce a unique partnership to raise awareness and funds for cancer research. As SU2C’s Official Domestic Airline partner, Virgin America (with Virgin Unite) has pledged to support SU2C’s mission through a multi-year in-kind travel partnership, Company [...]
[Story ID: 3349] Pacific Edge Biotechnology, the cancer diagnosis firm, has a pipeline of new products coming through after winning New Zealand patents for gastric cancer detection and melanoma prognostic technology, chief scientist Parry Guilford says.
[Story ID: 3311] Biotechnology company MabCure, Inc. today announced that a confirmatory study demonstrated the company’s proprietary monoclonal antibodies (MAbs) successfully identified ovarian cancer in blood (94 percent accuracy) and with no false positives or cross-reactions with benign ovarian tumors or healthy blood. MabCure’s serum diagnostic test is the first to recognize unique tumor markers [...]
[Story ID: 3313] A normally benign protein found in the human body appears to be able – when paired with nanoparticles – to zero in on and kill certain cancer cells, without having to also load those particles with chemotherapy drugs.The finding could lead to a new strategy for targeted cancer therapies, according to the [...]
[Story ID: 3248] ALBUQUERQUE, N.M.—-Manhattan Scientifics, Inc. said today that a July 20th New York Times article titled Prone to Error: Earliest Steps to Find Cancer highlights the potential value of the early cancer detection technology developed by Senior Scientific, LLC and licensed by Manhattan Scientifics.
[Story ID: 3217] The spread of cancer cells in the tongue may be reduced if a gene that regulates cancer cell migration can be controlled, according to new research at the University of Illinois at Chicago.
[Story ID: 3220] The National Cancer Institute has awarded Albert Einstein College of Medicine of Yeshiva University $4.1 million to test the microbicide Carraguard- against the human papillomavirus, which causes cervical cancer. The research will evaluate the efficacy of Carraguard- – a clear gel made from the seaweed derivative carrageenan – in preventing new HPV [...]
[Story ID: 3190] A new system that utilizes a precise a GPS-like system to track prostate cancer tumors is now being offered to patients undergoing radiation therapy at Cedars-Sinai’s Samuel Oschin Comprehensive Cancer Institute. The monitoring system, called Calypso, allows radiation beams to more precisely target the cancer as it gives real-time positioning information that [...]
[Story ID: 3191] A national survey announced today by Lung Cancer Alliance, sheds more light on why support for people affected by lung cancer remains low. The poll indicates Americans are more likely to view lung cancer as “hopeless” and “untreatable” when compared with a diagnosis of breast or colon cancer. In addition, 26% of [...]
[Story ID: 3155] A new study finds that African ancestry is linked to triple-negative breast cancer, a more aggressive type of cancer that has fewer treatment options.Researchers at the University of Michigan Comprehensive Cancer Center found that, among women with breast cancer, 82 percent of African women were triple negative, 26 percent of African-Americans were [...]